March 3, 2020 / 4:05 PM / a month ago

BRIEF-Chembio Diagnostics Has Accelerated Studies For Clia Waiver

March 3 (Reuters) - Chembio Diagnostics Inc:

* CHEMBIO DIAGNOSTICS PROVIDES UPDATE ON REGULATORY STATUS OF DPP HIV-SYPHILIS SYSTEM

* CHEMBIO DIAGNOSTICS INC - HAS ACCELERATED STUDIES FOR CLIA WAIVER, WHICH CAN BE SUBMITTED UPON FDA APPROVAL OF PMA APPLICATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below